Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma

被引:23
|
作者
Weibull, Caroline E. [1 ]
Eloranta, Sandra [1 ]
Smedby, Karin E. [1 ,2 ]
Bjorkholm, Magnus [2 ]
Kristinsson, Sigurdur Y. [2 ,4 ]
Johansson, Anna L. V. [1 ]
Dickman, Paul W. [1 ]
Glimelius, Ingrid [1 ,2 ,3 ]
机构
[1] Karolinska Inst, SE-17177 Stockholm, Sweden
[2] Karolinska Univ, Hosp Solna, Stockholm, Sweden
[3] Uppsala Univ, Uppsala, Sweden
[4] Univ Iceland, Reykjavik, Iceland
关键词
REGULATORY T-CELLS; FEMALE CANCER SURVIVORS; PROGNOSTIC-FACTOR; BREAST-CANCER; CARE PROGRAM; DISEASE; FERTILITY; SWEDEN; CHILDBEARING; PARENTHOOD;
D O I
10.1200/JCO.2015.63.3446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Many patients and clinicians are worried that pregnancy after the diagnosis of Hodgkin lymphoma (HL) may increase the risk of relapse despite a lack of empirical evidence to support such concerns. We investigated if an association exists between pregnancy and relapse in women with a diagnosis of HL. Materials and Methods Using Swedish healthcare registers combined with medical records, we included 449 women who received a diagnosis of HL between 1992 and 2009 and who were age 18 to 40 years at diagnosis. Follow-up started 6 months after diagnosis, when the patients' condition was assumed to be in remission. Pregnancy-associated relapse was defined as a relapse during pregnancy or within 5 years after delivery. Hazard ratios (HRs) with 95% CIs were estimated by using the Cox proportional hazards model. Results Among the 449 women, 144 (32%) became pregnant during follow-up. Overall, 47 relapses were recorded, of which one was a pregnancy-associated relapse. The adjusted HR for the comparison of the pregnancy-associated relapse rate to the non-pregnancy-associated relapse rate was 0.29 (95% CI, 0.04 to 2.18). The expected number of relapses in women with a recent pregnancy, given that they would experience the same relapse rate as that of women without a recent pregnancy, was 3.76; the observed-to-expected ratio was 0.27 (95% exact CI, 0.01 to 1.51). Conclusion We found no evidence that a pregnancy after diagnosis increases the relapse rate among women whose HL is in remission. Survivors of HL need to consider a range of factors when deciding about future reproduction. However, given the results of this study, the risk of pregnancy-associated relapse does not need to be considered.
引用
收藏
页码:337 / +
页数:10
相关论文
共 50 条
  • [21] The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
    Goldschmidt, Neta
    Or, Omer
    Klein, Martine
    Savitsky, Bella
    Paltiel, Ora
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 165 - 171
  • [22] The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
    Neta Goldschmidt
    Omer Or
    Martine Klein
    Bella Savitsky
    Ora Paltiel
    Annals of Hematology, 2011, 90 : 165 - 171
  • [23] Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy
    Pinnix, Chelsea C.
    Osborne, Eleanor M.
    Chihara, Dai
    Lai, Peter
    Zhou, Shouhao
    Ramirez, Mildred M.
    Oki, Yasuhiro
    Hagemeister, Frederick B.
    Rodriguez, Alma M.
    Samaniego, Felipe
    Fowler, Nathan
    Romaguera, Jorge E.
    Turturro, Francesco
    Fayad, Luis
    Westin, Jason R.
    Nastoupil, Loretta
    Neelapu, Sattva S.
    Cheah, Chan Y.
    Dabaja, Bouthaina S.
    Milgrom, Sarah A.
    Smith, Grace L.
    Horace, Patricia
    Milbourne, Andrea
    Wogan, Christine F.
    Ballas, Leslie
    Fanale, Michelle A.
    JAMA ONCOLOGY, 2016, 2 (08) : 1065 - 1069
  • [24] The cost of relapse in Hodgkin lymphoma.
    Hansen, Ryan N.
    Ramsey, Scott David
    Slejko, Julia
    Carlson, Josh John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Risk of second cancer in patients with Hodgkin Lymphoma who relapse after autologous stem cell transplantation
    Gotti, M.
    Colombo, A. A.
    Bernasconi, P.
    Caldera, D.
    Barate, C.
    Ripamonti, F.
    Pascutto, C.
    Lazzarino, M.
    Brusamolino, E.
    Alessandrino, E. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 244 - 245
  • [27] Obstetric and maternal outcome of 134 patients with Hodgkin lymphoma diagnosed during pregnancy: Results from the INCIP registry
    Amant, F.
    Maggen, C.
    Dierickx, D.
    Lugtenburg, E.
    Laenen, A.
    Cardonick, E.
    Shmakov, R. G.
    Casado, M. Bellido
    Garcia, A. C.
    Gziri, M.
    Halaska, M.
    Ottevanger, P.
    Van Calsteren, K.
    L'Hauglin, A.
    Polushkina, E.
    Van Dam, L.
    Vandenberghe, P.
    Woei-A-Jin, S. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients
    Biccler, Jorne Lionel
    Glimelius, Ingrid
    Eloranta, Sandra
    Smeland, Knut B.
    Brown, Peter de Nully
    Jakobsen, Lasse H.
    Frederiksen, Henrik
    Jerkeman, Mats
    Fossa, Alexander
    Andersson, Therese M. L.
    Holte, Harald, Jr.
    Bogsted, Martin
    El-Galaly, Tarec C.
    Smedby, Karin Ekstroem
    BLOOD, 2018, 132
  • [29] PATTERNS OF RELAPSE AMONG EARLY STAGE HODGKIN'S LYMPHOMA PATIENTS
    Singh, R.
    Samant, R.
    Alomary, I.
    Alsaeed, E.
    Al-Jasir, B.
    Bence-Bruckler, I.
    Cross, P.
    Huebsch, L.
    Genest, P.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S6 - S6
  • [30] Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients
    Ansell, Stephen M.
    Maurer, Matthew J.
    Ziesmer, Steven C.
    Siager, Susan L.
    Habermann, Thomas M.
    Link, Brian K.
    Witzig, Thomas E.
    Inwards, David James
    Colgan, Joseph P.
    Cerhan, James R.
    Novak, Anne J.
    BLOOD, 2011, 118 (21) : 198 - 198